Haukeland University Hospital is a hospital in Bergen, Norway, and one of the eleven institutions that make up Bergen Hospital Trust.

There are 1,100 beds in Department of Medcine, Haukeland University Hospital.

During the past decade, Department of Medcine, Haukeland University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Medcine, Haukeland University Hospital" are "Chronic Myelomonocytic Leukemia" (1 trials), "MDS" (1 trials), "MRD" (1 trials), "Myelodysplastic Syndrome" (1 trials) and "SCT" (1 trials). Many other conditions were trialed in "Department of Medcine, Haukeland University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Medcine, Haukeland University Hospital" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (1 trials) and "Erythropoetin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Medcine, Haukeland University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Medcine, Haukeland University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Medcine, Haukeland University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Medcine, Haukeland University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".